Rationale: Pathological cardiac myocyte hypertrophy is thought to be induced by the persistent increases in intracellular Ca 2؉ needed to maintain cardiac function when systolic wall stress is increased. Hypertrophic Ca 2؉ binds to calmodulin (CaM) and activates the phosphatase calcineurin (Cn) and CaM kinase (CaMK)II. Cn dephosphorylates cytoplasmic NFAT (nuclear factor of activated T cells), inducing its translocation to the nucleus where it activates antiapoptotic and hypertrophic target genes. Cytoplasmic CaMKII regulates Ca 2؉ handling proteins but whether or not it is directly involved in hypertrophic and survival signaling is not known. Objective: This study explored the hypothesis that cytoplasmic CaMKII reduces NFAT nuclear translocation by inhibiting the phosphatase activity of Cn. Methods and Results: Green fluorescent protein-tagged NFATc3 was used to determine the cellular location of NFAT in cultured neonatal rat ventricular myocytes (NRVMs) and adult feline ventricular myocytes. Constitutively active (CaMKII-CA) or dominant negative (CaMKII-DN) mutants of cytoplasmic targeted CaMKII ␦c were used to activate and inhibit cytoplasmic CaMKII activity. In NRVM CaMKII-DN (48.5؎3%, P<0.01 versus control) increased, whereas CaMKII-CA decreased (5.9؎1%, P<0.01 versus control) NFAT nuclear translocation (Control: 12.3؎1%). Cn inhibitors were used to show that these effects were caused by modulation of Cn activity. Increasing Ca 2؉ increased Cn-dependent NFAT translocation (to 71.7؎7%, P<0.01) and CaMKII-CA reduced this effect (to 17.6؎4%). CaMKII-CA increased TUNEL and caspase-3 activity (P<0.05). CaMKII directly phosphorylated Cn at Ser197 in CaMKII-CA infected NRVMs and in hypertrophied feline hearts. Conclusion: These data show that activation of cytoplasmic CaMKII inhibits NFAT nuclear translocation by phosphorylation and subsequent inhibition of Cn. (Circ Res. 2009;105:316-325.)
I ntermittent changes in the amplitude and duration of the systolic Ca 2ϩ transient are the principle mechanism for regulating the strength of contraction (contractility) of the heart in health. Cardiovascular diseases that cause persistent increases in systolic wall stress require sustained increases in Ca 2ϩ influx and sarcoplasmic reticulum uptake, storage and release to produce the necessary increases in [Ca 2ϩ ] required to maintain the pump function of the heart under these conditions. 1 The persistent increases in [Ca 2ϩ ] that are required to maintain cardiac pump function in pathological cardiovascular stress also activate complex signaling pathways that lead to cardiac hypertrophy, structural and functional remodeling, and cell death. 2 The signaling cascades that link changes in myocyte Ca 2ϩ to activation of hypertrophic and survival signaling are the topic of this study.
Increases in myocyte [Ca 2ϩ ] activate both the type 2B Ca 2ϩ /calmodulin (CaM)-dependent phosphatase, calcineurin (Cn), and the Ca 2ϩ /CaM-dependent protein kinase II (CaMKII). Activation of these signaling pathways is linked to electric and contractile disturbances in pathological cardiac hypertrophy. 3, 4 Activated Cn induces pathological hypertrophy by dephosphorylation and subsequent nuclear translocation of transcription factors associated with the NFAT family (nuclear factor of activated T cells) that activates specific hypertrophic target genes. 3, [5] [6] [7] [8] In mice, transgenic cardiac overexpression of a constitutively active form of Cn has been shown to cause hypertrophy, mechanical dysfunction, arrhythmias, and premature death. 3, 9 In larger animal models 10 and in patients, 11 increased Cn activity has been linked to structural heart disease and the development of heart failure.
Cn-mediated NFAT nuclear translocation also activates cardioprotective signaling. Cardiomyocytes with Cn-mediated hypertrophy are protected from ischemia/reperfusion-induced apoptosis both in vivo and in vitro. 12 In addition, Cnmediated NFAT activity inhibits the myocyte apoptosis induced by phenylephrine stimulation. 13 Importantly, although inhibition of Cn reduces cardiac hypertrophy, 3 it fails to reduce mortality or improve left ventricular function. 14 Collectively, these studies show that Cn-mediated NFAT nuclear translocation induces prohypertrophic and prosurvival signaling.
CaMKII is also activated in pathological cardiac stress and is associated with hypertrophy, mechanical dysfunction, arrhythmias, and myocyte apoptosis. 3, 9, 15 The signaling pathways linking CaMKII activity to these abnormalities are not as clearly defined as those for Cn. [15] [16] [17] CaMKII is a serine threonine kinase that is activated when increases in [Ca 2ϩ ] promote Ca 2ϩ binding to CaM and subsequently to CaMKII. Activated CaMKII promotes the transfer of the terminal phosphate of ATP to specific target proteins to influence their activity. 4, 18 CaMKII can also phosphorylate itself and this holoenzyme has catalytic activity that is independent of [Ca 2ϩ ]. This form of CaMKII is prevalent in cardiac stress states, 15, 18, 19 but its specific functional role is yet to be defined.
CaMKII signaling is complex because there are a number of CaMKII isoforms with different cellular locals. CaMKII␦ is the predominant isoform in the heart, 18, 20, 21 with ␦ B and ␦ c being the major splice variants. The major difference between these 2 isoforms is that ␦ B contains a nuclear localization signal, and ␦ c , does not. 18, 22, 23 Therefore CaMKII ␦ B subunits localize to the nucleus, whereas ␦ c localize to the cytoplasm. 18, 22, 23 Activation of the nuclear CaMKII␦ B is linked to the activation of hypertrophic signaling by phosphorylating nuclear histone deacetylases (repressors of gene expression) and inducing their export from the nucleus. 23 Activation of cytoplasmically restrained CaMKII␦ c causes well-known effects on Ca 2ϩ handling proteins, but its role in the induction of pathological hypertrophy or survival signaling is not known.
CaMKII␦ c regulates the activity of Ca 2ϩ handling proteins in the heart, 4 and excess CaMKII␦ c activity could mediate cardiomyopathic signaling in patients with end-stage heart failure by disrupting myocyte Ca 2ϩ handling. 18, 24, 25 In animal models, transgenic overexpression of CaMKII causes myocardial dilation, dysfunction, and abnormal myocyte Ca 2ϩ homeostasis. 15, 25 CaMKII-mediated phosphorylation of Ca 2ϩ regulatory proteins, such as the L-type Ca 2ϩ channel, 4,26 the ryanodine receptor, 15, 25 and phospholamban (PLB), 4, 15 are likely to be involved in the pathogenesis of dilated cardiomyopathy, 15 cardiomyocyte apoptosis, 27 arrhythmias, 16 and heart failure. 18 The fact that inhibition of CaMKII protects against cardiac structural and functional defects after myocardial infarction supports that it plays a critical role in these disturbances. 28 Although both Cn and CaMKII␦ c are activated by changes in cytoplasmic Ca 2ϩ , the idea that these 2 signaling cascades directly interact to modulate hypertrophic and survival signaling has not been well studied. The activity and expression of CaMKII are increased in hearts from Cn-overexpressing mice and CaMKII inhibition improves left ventricular function. 16 These results suggest that CaMKII might mediate some of its cardiomyopathic effects by modulating Cn signaling. 16 Further support for this idea comes from studies in human T Cells where an active form of CaMKII was shown to decrease NFAT activity by nearly 35%. 29 The idea that activation of cytoplasmic CaMKII(␦ c ) modulates cardiomyopathic signaling by regulating Cnmediated NFAT nuclear translocation is the central topic of this study.
The working hypothesis of this study is that constitutive activation of the cytoplasmically localized isoform of CaMKII(␦ c ) regulates myocyte stress responses (hypertrophy and cell survival signaling) by modulating (inhibition) Cnmediated NFAT nuclear translocation. We specifically tested the idea that the autophosphorylated, constitutively (Ca 2ϩindependent) active (CA) form of cytoplasmic CaMKII(␦ c ) regulates Cn-mediated NFAT nuclear translocation. Our studies show that CaMKII␦ c -CA reduces myocyte contractility, inhibits NFAT nuclear translocation and hypertrophic signaling and induces myocyte apoptosis. These findings demonstrate a previously unappreciated role of cytoplasmic CaMKII in cardiac myocytes and suggest that inhibition of the autophosphorylated form of CaMKII␦ c may be a viable strategy for improving myocardial function in heart disease.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Construction of Viral Vectors
Hemagglutinin (HA)-tagged constitutively active CaMKII␦ c (CaMKII-CA) and dominant negative CaMKII␦ c (CaMKII-DN) were kindly provided by Dr Joan Heller Brown. 23 Green fluorescent protein (GFP)-tagged NFATc3 (adNFATc3) 30 was used to determine cytoplasmic versus nuclear NFAT localization. Nuclei with NFATc3-GFP fluorescence that was 2ϫ above cytoplasmic NFAT-GFP fluorescence were deemed to be NFAT positive. 31, 32 Feline left ventricular myocytes were isolated as described previously. 33, 34 Myocytes were infected with adNFATc3 and subsets were coinfected with CaMKII-CA or CaMKII-DN for 6 hours at a multiplicity of infection of 100.
Cell Culture and Adenoviral Gene Transfer

TUNEL and Caspase Assays
The TUNEL assay was performed with NFATc3-GFP-expressing NRVMs attached to coverslips using the In Situ Cell Death Detection Kit (TMR Red) (Roche Applied Science, Indianapolis, Ind). The number of TUNEL-positive nuclei from GFP-positive NRVMs as a percentage of the total nuclei was counted in a minimum of 10 random fields per isolation. Caspase 3 activity was measured with EnzChek Caspase-3 (Molecular Probes) assay kit according to the instructions of the manufacture, with minor modifications.
Immunoprecipitation and Western Blotting
NRVMs were infected with or without specific adenoviruses for 48 hours, protein was collected, and immunoprecipitation and Western blotting performed.
Tissue protein abundance and phosphorylation in isolated protein were analyzed using Western blot analysis as previously described. 35 
Feline Physiological Measurement
All experiments were performed on single rod-shaped myocytes with clear sarcomeric cross striations as previously described. 36 
Results
Adenoviral Gene Transfer of adNFATc3-GFP and CaMKII in Neonatal Cardiac Myocytes
Infection rates of 96% were achieved with adNFATc3-GFP and Ͼ99% for both CaMKII-CA and CaMKII-DN ( Figure 1 ). Anti-HA staining confirmed the cytoplasmic localization of both CaMKII␦ c isoforms and expression was quantified by Western blotting (Figure 1 ). PLB phosphorylation at Thr17 (PLB-Thr17), a known CaMKII phosphorylation site, was increased only in CaMKII-CA, demonstrating that CaMKII activity was increased in these myocytes.
NFAT Translocation in Neonatal Ventricular Myocytes
In our control conditions, NFATc3 was primarily localized in the cytoplasm but had been translocated into the nucleus in 12.4Ϯ1.4% of NRVMs (Figure 2A (2 mol/L), or calcineurin inhibitor (CAIN) (2.5 mol/L) all significantly reduced NFAT translocation in control and CaMKII-DN myocytes, but not in myocytes infected with CaMKII-CA. These results support the idea that NFATc3 nuclear translocation in control and CaMKII-DN myocytes is dependent on Cn activation and that basal Cn signaling is regulated by the activation state of CaMKII. To further support a role for CaMKII in Cn-mediated NFATc3 nuclear translocation, CaMKII-CA infected NRVMs were treated with the CaMKII inhibitor autocamtide 2-related inhibitory peptide (AIP) (Online Figure I ). AIP induced a dosedependent increase in NFATc3 nuclear translocation, supporting the idea that CaMKII directly modulates Cn signaling, even under basal conditions.
Calcium-Dependent NFAT Translocation
NFAT translocates from the cytoplasm to the nucleus in stress states when myocyte Ca 2ϩ is increased. 3 To prove that our system was also sensitive to changes in myocyte Ca 2ϩ , we tested the effects of 4 mmol/L bath [Ca 2ϩ ] on NFATc3 nuclear translocation ( Figure 3 and Online Figure II Figure 3C ). These results show that Ca 2ϩ -mediated NFATc3 nuclear translocation requires Cn activation and suggests that activated CaMKII is a negative regulator of this process.
CaMKII-Mediated Cardiomyocytes Apoptosis
Cardiovascular stress states that involve increased myocyte [Ca 2ϩ ] are associated with activation of CaMKII and an increased rate of myocyte death. 27 We explored the idea that activation of cytoplasmic CaMKII(␦ c ) promotes myocyte death signaling, at least partially by regulating NFAT nuclear translocation. The TUNEL assay was used to measure the percentage of myocytes undergoing apoptosis. In control conditions, the percentage of TUNEL-positive myocytes was greater in CaMKII-CA versus both adNFATc3 and CaMKII-DN myocytes ( Figure 4A ). Increasing the bath [Ca 2ϩ ] o to 4 mmol/L increased the percentage of TUNELpositive cells in both adNFATc3 and CaMKII-CA myocytes, but not in CaMKII-DN-infected cells ( Figure 4A ). Caspase-3 activity was increased in myocytes expressing CaMKII-CA, whereas no differences were observed with control or CaMKII-DN ( Figure 4B and 4C ). Coexpression of CA and DN was able to blunt the increased caspase activity observed in CaMKII-CA ( Figure 4B and 4C) . These studies show that Ca 2ϩ induced myocyte apoptosis is enhanced by CaMKII(␦ c )-CA and is reduced by CaMKII(␦ c )-DN.
CaMKII-Mediated Cn Phosphorylation
Our experiments have shown that CaMKII(␦ c ) activity influences Cn mediated NFATc3 nuclear translocation. To define the mechanism for this effect we next tested if activated CaMKII maintains NFATc3 in the cytoplasm by directly phosphorylating it or by phosphorylation and inhibition of Cn. The phosphorylation status of NFAT in myocytes expressing CaMKII-CA or CaMKII-DN, was determined by immunoprecipitation of NFAT-GFP (IP:GFP) followed by Western analysis with antibodies against phospho-serine or phosphothreonine ( Figure 5A ). Phosphorylation (serine and threonine) of NFAT was greatest in CaMKII-CA and lowest in CaMKII-DN, consistent with the cytoplasmic and nuclear NFATc3 localization displayed in Figure 2 . These results strongly support the idea that cytoplasmic CaMKII activity regulates NFAT phosphorylation state, although they do not discern between direct phosphorylation of NFAT by CaMKII or an effect mediated by alterations in Cn activity. Indeed, although glycogen synthase kinase 3, p38, and c-Jun N-terminal kinase are kinases that directly phosphorylate NFAT, [37] [38] [39] resulting in nuclear export/cytoplasmic localization, it is not known whether CaMKII directly phosphorylates NFAT. To explore direct CaMKII-NFAT or CaMKII-Cn interactions, in vitro kinase assays were performed ( Figure  5B ). We could not identify direct CaMKII phosphorylation of NFATc3 in any of 3 recombinant protein fragments that together comprise the entire protein (N 1 , N 2 , or N 3 ). However, in multiple experiments, we were able to show that recombinant CaMKII directly phosphorylated purified Cn ( Figure 5B ).
CaMKII phosphorylation of Cn at Ser197 is known to inhibit its activity. 40 -42 We generated an antibody with some ability to detect Cn-Ser197 phosphorylation. With this antibody, we found Cn-Ser197 phosphorylation in NRVMs expressing CaMKII-CA ( Figure 6A ) but with little detectable levels under our other conditions. PLB phosphorylation at Thr17 was also increased in CaMKII-CA myocytes, consistent with increased CaMKII activity.
Cn-mediated translocation of NFAT from the cytoplasm to the nucleus is known to activate hypertrophic gene expression. We measured the hypertrophic marker atrial natriuretic peptide to determine whether the nuclear NFATc3 translocation induced by CaMKII-CA and -DN activated hypertrophic signaling. Atrial natriuretic peptide protein abundance was significantly (PϽ0.05) reduced in myocytes expressing CaMKII-CA and significantly increased (PϽ0.05) in myocytes expressing CaMKII-DN, consistent with our contention that CaMKII reduces hypertrophic and cardioprotective signaling by opposing Cn-mediated NFATc3 nuclear translocation.
Cn-Ser197-Phosphorylation in Feline Hypertrophy
Pathological signaling involving Ca 2ϩ may not be similar in rodents and larger mammals because of fundamental differences in Ca 2ϩ handling in large and small mammals. 43, 44 To determine whether increased phosphorylation at Cn-Ser197 is present in the intact heart of a large mammal (with Ca 2ϩ handling like that in humans) 45 subjected to chronic myocardial stress, samples were collected from left ventricular tissue from aortic banded felines 34 and analyzed via Western blot analysis. Greater phosphorylation of Cn at Ser197 was observed in hypertrophied feline left ventricular tissue (Figure 6B ). In these animals, we were able to detect Ser197 phosphorylation in control hearts. These data strongly support the idea that the observations in NRVMs are relevant to cardiac disease states.
Adult Ventricular Myocytes: NFAT Nuclear Translocation and Functional Analysis
The effects of CaMKII on NFATc3 nuclear translocation were also studied in adult feline ventricular myocytes to ensure that our results in NRVMs are relevant to the adult heart of a large mammal. In addition, these myocytes were used to examine the effects of CaMKII activity on contractile function. In feline myocytes, an infection rate of 97% was achieved with adNFATc3 and 98% for both CaMKII-CA and CaMKII-DN. CaMKII␦ c was localized to the cytoplasm and PLB-Thr17 was highest in myocytes expressing CaMKII-CA ( Figure 7A and 7B), as we have shown for NRVMs. NFATc3 nuclear localization was greatest in myocytes expressing CaMKII-DN (55.1Ϯ3.8%, PϽ0.01) versus adNFATc3-GFP (24.8Ϯ1.9%) and was lowest in CaMKII-CA (18.9Ϯ2.1%). These results are similar to those in NRVMs. Pacing feline myocytes, which are normally quiescent in culture, induced NFATc3 nuclear translocation that was frequency-dependent. Pacing-induced NFATc3 nuclear translocation was inhibited by CsA ( Figure 7C ), demonstrating the role of Cn. These experiments show that CaMKII-CA and DN have similar effects on NFATc3 nuclear translocation in neonatal and adult myocytes.
Feline ventricular myocytes expressing CaMKII-CA had smaller fractional shortening and ϮdL/dt values than myocytes expressing either control (adNFATc3) or CaMKII-DN ( Figure 7D and 7E) . These studies suggest that in spite of the known effects of CaMKII to increase Ca 2ϩ influx and Figure 6 . A, To demonstrate protein abundance and phosphorylation state of proteins involved in this signaling cascade, protein extracts were made from cultured NRVMs expressing CaMKII-CA or CaMKII-DN, whereas GFP acted as a control. The phosphorylation of Cn at Ser197 was detectable only in NRVMs expressing CaMKII-CA ( Figure 6A ), whereas PLB phosphorylation was increased at Thr17, consistent with increased CaMKII activity. A reduction in atrial natriuretic peptide (ANP) abundance was observed in myocytes expressing CaMKII-CA, consistent with reduced hypertrophic signaling. B, An increase in phosphorylation of Cn at Ser197 was observed in hypertrophied feline left ventricular tissue. promote sarcoplasmic reticulum Ca 2ϩ uptake, the net effect is to reduce myocyte contractility, at least under our conditions (see Discussion).
Discussion
Cardiovascular diseases such as hypertension and myocardial infarction raise the contractile stress on the heart. This requires reflex responses (primarily via the sympathetic nervous system) that increase cardiac systolic stress generation by producing increases in myocyte [Ca 2ϩ ]. When excess contractile stress is persistent, it leads to cardiac hypertrophy and over time is associated with arrhythmias, myocyte death, and eventually congestive heart failure. 2, 46 The links among persistent increases in myocyte Ca 2ϩ , pathological hypertrophy, cardiac arrhythmias, and myocyte contractile abnormalities are still not well established. 3, 9, 15 Increased myocyte Ca 2ϩ activates Cn, a phosphatase that dephosphorylates and thereby induces nuclear translocation of NFAT, which is involved in the induction of pathological cardiac hypertrophy and prosurvival signaling. 3, [5] [6] [7] [8] 12, 13 Increased myocyte Ca 2ϩ also activates cytoplasmic CaMKII (␦ c) , which phosphorylates a number of critical target proteins involved in Ca 2ϩ regulation. Although the effects of CaMKII on individual Ca 2ϩ regulatory proteins is fairly well described, its role in the regulation of cardiac contractility is complex and its role as a regulator of NFAT mediated cardiac gene expression and cell death are not, to our knowledge, known.
The central question of the present research was whether activation of (cytoplasmic) CaMKII␦ c was involved in the regulation of NFAT nuclear translocation and, if so, to determine the molecular signaling pathway(s) involved. Our results clearly show that, at least under our experimental conditions, activation of CaMKII␦ c (with ad-CaMKII-CA) increases NFAT phosphorylation state (indirectly) and reduces NFAT nuclear translocation, whereas inhibition of CaMKII␦ c (with ad-CaMKII-DN or AIP) reduces NFAT phosphorylation (indirectly) and induces NFAT translocation from the cytoplasm to the nucleus. The novel aspect of our study is that we show that CaMKII␦ c induces these differences in NFAT phosphorylation, by modulating the activity of Cn. Other kinases that alter Cn-NFAT signaling (glycogen synthase kinase, p38m c-Jun N-terminal kinase, protein kinase A, MEKK1, CKII) do so by directly phosphorylating the N terminus of NFATc1-c4, within the regulatory domain that controls nuclear shuttling by masking and unmasking a NLS. [37] [38] [39] However, in our hands, CaMKII did not directly phosphorylate NFAT, but, instead, we showed it directly phosphorylated Cn. These data were confirmed using a phosphorylation specific antibody against the Ser197 on Cn, a site previously shown to be phosphorylated by the autophosphorylated form of CaMKII and this interaction results in and partial inactivation of Cn. 40 -42 Our results suggest that phosphorylation of Cn by CaMKII inhibits its phosphatase activity, allowing NFAT to be more phosphorylated and maintained within the cytoplasm. We found that CaMKII-CA/DN, as well as Cn and CaMKII inhibitors, altered NFAT translocation to the nucleus at baseline. These results suggest that both CaMKII and Cn are functionally active under basal conditions and that CaMKII is a modulator of this basal activity. Our results further support the idea that increases in myocyte Ca 2ϩ activate 2 cytoplasmic signaling cascades with opposite effects on Cn activity, and, together, they determine NFAT nuclear translocation, hypertrophy and pro survival signaling (Figure 8) . Clearly, increased Cnmediated NFAT nuclear translocation was the dominant effect of increased Ca 2ϩ , with CaMKII acting as a negative regulator.
CaMKII-mediated phosphorylation of Cn has been described previously, 40 -42 and we confirmed that CaMKII␦ c directly phosphorylates calcineurin in vitro. This phosphorylation occurs on the Ser197 residue which is located in the C-terminal boundary of the putative Ca 2ϩ /CaM binding domain. 41 This phosphorylation appears to be blocked when Ca 2ϩ /CaM is bound to Cn, suggesting interaction between this phosphorylation site and the CaM binding domain. 41 Phosphorylation of Cn-Ser197 by CaMKII results in partial inactivation of Cn as evidenced by an increase in K m for protein substrates. 41 Phosphorylation and partial inactivation of Cn in vivo would enhance phosphorylation of those proteins normally dephosphorylated by Cn such as tubulin, 47 protein phosphatase inhibitor 1, 48 apoptosis signal-regulating kinase 1, 39 and NFAT. We showed that NFAT phosphorylation was increased in myocytes expressing the CaMKII-CA and in hypertrophied feline hearts, consistent with the central hypothesis of this study.
Increasing Ca 2ϩ in either neonatal or adult ventricular myocytes induced NFAT nuclear translocation and this translocation was abolished by Cn inhibitors. These results suggest that when Ca 2ϩ is increased in normal myocytes the net effect is to activate Cn such that NFAT is dephosphorylated and translocates into the nucleus. Activation of CaMKII appears to negatively regulate this signaling cascade providing additional control. When we increased the activity of CaMKII with CaMKII-CA, the effects of increased Ca 2ϩ on NFAT nuclear translocation were significantly smaller, and when CaMKII activity was reduced with CaMKII-DN or AIP, the Ca 2ϩ effects were enhanced. Collectively, these results show that cytoplasmic CaMKII is a critical negative regulator of Cn and NFAT nuclear translocation.
CaMKII activity is significantly increased in cardiovascular stress states that eventually lead to structural and functional remodeling. The excessive adrenergic activity needed to maintain cardiac pump function in the face of increased contractility demands, overtime, causes significant changes in adrenergic and CaMKII signaling, with ␤-adrenergic signaling downregulated 35, 49, 50 and CaMKII signaling enhanced. 18, 24 Recent studies by Anderson and colleagues 16, 28 have shown that inhibition of CaMKII in this context can have beneficial effects on cardiac function and reduces myocyte apoptosis. The bases of these beneficial effects are not yet clear and could involve both cytoplasmic and nuclear CaMKII. Some of the beneficial effects of CaMKII inhibition in heart disease could also be attributable to removal of excess phosphorylation of Ca 2ϩ regulatory proteins through inhibition of cytoplasmic CaMKII. In addition, inhibition of nuclear CaMKII could reset hypertrophic signaling cascades. Our data suggest that an additional explanation for the beneficial effects of CaMKII inhibitors in the failing heart is by removing the inhibitory effect of cytoplasmic CaMKII on Cn, thereby increasing NFAT nuclear translocation and unleashing its cardioprotective features. Many additional studies are required to sort through these issues.
Collectively, our results demonstrate that the constitutively activate form of CaMKII␦ c directly phosphorylates Cn and inhibits its activity, resulting in reduced NFAT nuclear translocation and increased myocyte apoptosis. In cardiac disease states in which CaMKII activation is known to be increased, its effects on Cn could disrupt NFAT signaling and contribute to cardiac structural and functional defects. Thus, as suggested by others, 28, 51 inhibition of the excessive CaMKII activity of the failing heart may be an effective strategy for improving myocardial function in heart disease.
Limitations
We studied the relationship between CaMKII and Cn using in vitro-forced overexpression of either constitutively active of dominant negative mutant proteins. The mechanistic insights defined will need to be explored further in genetically modified mouse models with normal levels of expressed protein. The sources of Ca 2ϩ to selectively activate CaMKII in the nucleus and cytoplasm and cytoplasmic Cn also need to be studied further.
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